Laboratory Corporation of America Holdings
NYSE:LH
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
191.8992
246.22
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
LH Price Targets Summary
Laboratory Corporation of America Holdings
According to Wall Street analysts, the average 1-year price target for LH is 269.01 USD with a low forecast of 233.31 USD and a high forecast of 307.65 USD.
LH Last Price Targets
Laboratory Corporation of America Holdings
The latest public price target was made on Sep 24, 2024 by Elizabeth Anderson from Evercore ISI , who expects LH stock to rise by 0% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Elizabeth Anderson
Evercore ISI
|
240
USD
Upside 0% |
2 months ago
Sep 24, 2024
|
Labcorp price target lowered to $240 from $250 at Evercore ISI
TheFly
|
Brian Tanquilut
Jefferies
|
265
USD
Upside 11% |
2 months ago
Sep 23, 2024
|
Laboratory Corporation of America (LH) PT Raised to $265 at Jefferies
StreetInsider
|
Michael Ryskin
Bank of America Securities
|
260
USD
Upside 8% |
3 months ago
Aug 5, 2024
|
Labcorp price target raised to $260 from $240 at BofA
TheFly
|
Eric Coldwell
Robert W. Baird
|
277
USD
Upside 16% |
3 months ago
Aug 2, 2024
|
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Benzinga
|
Stephanie Davis
Barclays
|
249
USD
Upside 4% |
3 months ago
Aug 2, 2024
|
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
Benzinga
|
David Toung
Argus Research
|
250
USD
Upside 4% |
7 months ago
Mar 25, 2024
|
Argus Upgrades Laboratory Corporation of America (LH) to Buy on stronger top-line growth and margin expansion
StreetInsider
|
Revenue
Forecast
Revenue Estimate
Laboratory Corporation of America Holdings
For the last 8 years the compound annual growth rate for Laboratory Corporation of America Holdings's revenue is 4%. The projected CAGR for the next 3 years is 7%.
Operating Income
Forecast
Operating Income Estimate
Laboratory Corporation of America Holdings
For the last 8 years the compound annual growth rate for Laboratory Corporation of America Holdings's operating income is 0%. The projected CAGR for the next 3 years is 25%.
Net Income
Forecast
Net Income Estimate
Laboratory Corporation of America Holdings
For the last 8 years the compound annual growth rate for Laboratory Corporation of America Holdings's net income is -1%. The projected CAGR for the next 3 years is 54%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LH's stock price target?
Price Target
269.01
USD
According to Wall Street analysts, the average 1-year price target for LH is 269.01 USD with a low forecast of 233.31 USD and a high forecast of 307.65 USD.
What is Laboratory Corporation of America Holdings's Revenue forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Laboratory Corporation of America Holdings's revenue is 4%. The projected CAGR for the next 3 years is 7%.
What is Laboratory Corporation of America Holdings's Operating Income forecast?
Projected CAGR
25%
For the last 8 years the compound annual growth rate for Laboratory Corporation of America Holdings's operating income is 0%. The projected CAGR for the next 3 years is 25%.
What is Laboratory Corporation of America Holdings's Net Income forecast?
Projected CAGR
54%
For the last 8 years the compound annual growth rate for Laboratory Corporation of America Holdings's net income is -1%. The projected CAGR for the next 3 years is 54%.